Chinese pharmaceutical companies have recently engaged in multiple out-licensing agreements with international partners, highlighting China’s increasing significance as a source for innovative medicin...

Biotech firm Insilico Medicine has secured a partnership worth up to US$888 million with French pharmaceutical company Servier for the development of new cancer drugs using artificial intelligence tec...